Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30250% above fair value
$148.36−1.16 (-0.78%)
Close on Nov 2, 2026Market cap $366.03BP/E 118.7Yield 2.21%
Merck Merck US Savings Plan (Form 11-K) by Year
Merck US Savings Plan (Form 11-K) — Net Investment Gain (Loss) from Master Trust ($M) ($M)
Merck Merck US Savings Plan (Form 11-K): $2,392,957M in FY2025, up 30.1% from a year earlier.
Latest, FY2025
2,392,957
Period ended Dec 31, 2025
Change on a year earlier
+30.1%
1,839,883 in FY2024
History
5 years
Since FY2018
Sources
5
Documents cited below
Where the FY2025 figure comes from
“|| Plan interest in Master Trust investment gain | $ | 2,392,957”
Source: Form 11-K (mrk-20260624.htm, filed 2026-06-24) ↗
Reported in Form 11-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Merck US Savings Plan (Form 11-K) — Net Investment Gain (Loss) from Master Trust ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,392,957 | +30.1% | Form 11-K (mrk-20260624.htm, filed 2026-06-24) ↗ |
| FY2024 | Dec 31, 2024 | 1,839,883 | -7.9% | Form 11-K (a11-k_merckussavingsplanye.htm, filed 2025-06-27) ↗ |
| FY2023 | Dec 31, 2023 | 1,998,549 | -207.8% | Form 11-K (a11-k_merckussavingsplanye.htm, filed 2024-06-25) ↗ |
| FY2022 | Dec 31, 2022 | -1,853,703 | – | Form 11-K (a11-k_merckussavingsplanye.htm, filed 2023-06-27) ↗ |
| FY2018 | Dec 31, 2018 | -264,805 | – | Form 11-K (a11-k_merckussavingsplan20.htm, filed 2019-06-20) ↗ |
Cite this data
StockData. (2026). Merck Merck US Savings Plan (Form 11-K) ($M), annual FY2018–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/plan11k-us-savings-inv-inc
See every metric in the Merck KPI table. Data updated Oct 26, 2026.